The authors developed two complementary human induced pluripotent stem cell (iPSC)-derived neuron models to study Tau-driven neurodegeneration relevant to Alzheimer’s disease and related tauopathies. One model uses an endogenous Tau seeding approach in which neurons are challenged with pre-formed Tau fragments that assemble into structures consistent with paired helical filaments (PHFs). The second model employs Tau-0N3R overexpression seeding to accelerate pathology. Both systems are described as recapitulating hallmark features of tauopathy, including disruptions of synaptic integrity and neuronal communication that contribute to cognitive decline. The provided abstract text is truncated in the source and ends before enumerating the specific hallmarks, assays, or quantitative outcomes.
The study presents two distinct but complementary iPSC-neuron approaches to generate human-relevant Tau pathology. The first, an endogenous Tau seeding model, introduces pre-formed Tau fragments to otherwise unmodified human neurons to trigger aggregation. The fragments reportedly form assemblies consistent with paired helical filament (PHF) morphology.
The second approach, a Tau-0N3R overexpression seeding model, increases neuronal expression of a specific Tau isoform (0N3R) and applies a seeding paradigm to accelerate development of Tau pathology. The combination of genetic overexpression and seeding is intended to shorten experimental timelines while retaining features considered relevant to disease.
The abstract emphasizes that these models are intended to be reliable and scalable for mechanistic studies and therapeutic discovery, but details of cell lines, differentiation protocols, seeding concentrations, time courses, or validation steps were not reported in the supplied excerpt.
According to the abstract, both models reproduce hallmark features of tauopathy seen in human disease. The authors highlight disruption of synaptic integrity and impaired neuronal communication as downstream consequences of pathological Tau aggregation, consistent with the role of hyperphosphorylated and fibrillar Tau in cognitive decline.
Because the source text provided is incomplete, the specific set of hallmarks (for example, Tau post-translational modifications, biochemical fractionation results, ultrastructural characterization, electrophysiology, synaptic protein loss, or cell viability measures) are not listed here. The abstract was truncated before those details were presented, so readers should consult the full preprint for exact phenotypic readouts and how they were measured.
The central aim described is to reveal mechanisms that connect Tau fibrillization to synaptic dysfunction in human neurons. The models are designed to allow controlled induction of fibril-like Tau assemblies (PHF-consistent structures) and to observe resultant effects on neuronal function and synaptic integrity.
The excerpt does not include mechanistic data, pathway analyses, or experimental evidence delineating how fibrillization causes synaptic changes (for example, whether via mislocalization of Tau, synaptic protein depletion, altered axonal transport, or activation of specific signaling cascades). Those mechanistic findings and any intermediary molecular players were not reported in the supplied source material.
The abstract emphasizes that reliable, scalable human neuron models are essential for dissecting pathogenesis and enabling therapeutic discovery. The two described systems—an endogenous seeding paradigm and an accelerated overexpression-seeding paradigm—are framed as complementary tools that can be used for:
Specifics about throughput (e.g., well formats, assay automation), assay endpoints used for screening, or example screening outcomes were not provided in the excerpt.
The provided source text contains only the opening portion of the abstract and is truncated mid-sentence. As a result, critical experimental details and findings are missing from the excerpt made available here. Information not reported in the supplied text includes, but may not be limited to:
Because those items are not present in the supplied abstract fragment, they cannot be asserted here and must be obtained from the full preprint.
This preprint reports development of two scalable human iPSC-neuron models to study Tau fibrillization and its effects on synaptic integrity—an endogenous Tau seeding model and a Tau-0N3R overexpression seeding model. Both are presented as recapitulating core aspects of tauopathy relevant to Alzheimer’s disease, with the stated goal of enabling mechanistic investigation and therapeutic discovery. The excerpt provided is incomplete: readers should consult the full preprint for comprehensive methods, results, and interpretation. The article is a preprint and has not undergone peer review, as noted in the source.